The influence of some selected antiepileptic drugs in combination with arachinodyl-2-chlorethylamide, a selective cannabinoid CB1 receptor on neurogenesis in the mouse pilocarpine model of epilepsy

2012/05/B/NZ7/02459

Keywords

Descriptors

  • NZ4_10: Neuroobrazowanie
  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Medycyny Wsi im. Witolda Chodźki

Voivodeship: lubelskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Marta Andres-Mach

Number of co-investigators in the project: 6

Call

OPUS 3 – announced on 2012-03-15

Amount awarded
293 150 PLN
Project start date
2013-02-25
Project end date
2017-02-24
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. Mikrotom SM2010 LEICA. Cost: 40 000 PLN
  2. Urządzenie sterujące z oprogramowaniem do ilościowej analizy komórek NeuN, GAP, oraz BrdU-pozytywnych (Zeiss lub Nikon). Cost: 7 000 PLN
  3. Wytrząsarka orbitalna (Sigma-Sldrich). Cost: 5 000 PLN

Information in the final report

Publication in academic press/journals (4)

  1. ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs.

    Authors:
    Andres-Mach M, Haratym-Maj A, Zagaja M, Rola R, Maj M, Chrościńska-Krawczyk M, Luszczki JJ.
    Academic press:
    Brain Research (year: 2015, volume: 1624, pages: 86-94), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.brainres.2015.07.028 – link to the publication
  2. A Long-Term Treatment with Arachidonyl-2′-Chloroethylamide Combined with Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of Epilepsy

    Authors:
    Marta Andres-Mach, Mirosław Zagaja, Agnieszka Haratym-Maj, Radosław Rola, Monika Dudra-Jastrzębska, Maciej Maj, Joanna Haratym, Jarogniew J. Łuszczki
    Academic press:
    International Journal of Molecular Science (year: 2017, volume: 18, pages: 900), Publisher: Multidisciplinary Digital Publishing Institute
    Status:
    Published
    DOI:
    10.3390/ijms18050900 – link to the publication
  3. Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain.

    Authors:
    Mirosław Zagaja; Agnieszka Haratym-Maj; Aleksandra Szewczyk; Radoslaw Rola; Maciej Maj; Jarogniew Łuszczki; Marta Andres- Mach
    Academic press:
    Neuroscience Letters (year: 2019, volume: 23;696, pages: 79-86), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.neulet.2018.12.016 – link to the publication
  4. Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies

    Authors:
    Krzysztof Łukawski, Marta Andres-Mach, Mirosław Czuczwar, Jarogniew J.Łuszczki, Krzysztof Kruszyński, Stanisław J.Czuczwar
    Academic press:
    Pharmacological Reports (year: 2018, volume: 70, pages: 284-293), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pharep.2017.07.012 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski